Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FURIN | P09958 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 3/20 | 0.39 |
| ▸ | PPARA | Q07869 | 3/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.39 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12641556 | 0.95 | FURIN (0.44) | FURINL3MBTL1GAAPLA2G4BCA12 | |
| SCHEMBL14107991 | 0.89 | PPARA (0.42) | FURINL3MBTL1GAAPLA2G4BTSHR | |
| SCHEMBL2607803 | 0.89 | FURIN (0.40) | FURINL3MBTL1GAAPLA2G4BCA12 | |
| SCHEMBL546603 | 0.84 | CA12 (0.44) | L3MBTL1PLA2G4BCA12CA1CA2 | |
| SCHEMBL546602 | 0.84 | CA12 (0.44) | L3MBTL1PLA2G4BCA12CA1CA2 | |
| SCHEMBL2610224 | 0.84 | CA12 (0.44) | L3MBTL1PLA2G4BCA12CA1CA2 | |
| SCHEMBL12551463 | 0.82 | FURIN (0.40) | FURINL3MBTL1GAAPLA2G4BCA12 | |
| SCHEMBL17122443 | 0.82 | MAPT (0.46) | FURINL3MBTL1CA1CA2CA9 | |
| SCHEMBL17762976 | 0.82 | CA12 (0.40) | FURINL3MBTL1GAAPLA2G4BCA12 | |
| SCHEMBL17452135 | 0.81 | FURIN (0.43) | FURINL3MBTL1GAAPLA2G4BCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8241822-B2 | Halogenated oxime derivatives and the use therof as latent acids | BASF SE (DE) | 2012-08-14 | — | — | US | disclosed |
| US-20090042114-A1 | Halogenated oxime derivatives and the use therof as latent acids | YAMATO HITOSHI | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042114-A1 | Halogenated oxime derivatives and the use therof as latent acids | AHR, CCNT1, RTF1 | FURIN 1113/4885L3MBTL1 25/4885GAA 3626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.